RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.63B
AUM Growth
-$522M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
100
New
Increased
Reduced
Closed

Top Buys

1
+$479M
2
+$122M
3
+$84.9M
4
BOLT icon
Bolt Biotherapeutics
BOLT
+$78.3M
5
MCRB icon
Seres Therapeutics
MCRB
+$76.1M

Top Sells

1
+$312M
2
+$195M
3
+$143M
4
KROS icon
Keros Therapeutics
KROS
+$132M
5
FPRX
Five Prime Therapeutics, Inc.
FPRX
+$72.9M

Sector Composition

1 Healthcare 95.53%
2 Financials 0.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$826M 12.46%
6,412,228
+546,890
2
$544M 8.21%
3,002,087
-786,477
3
$479M 7.23%
+11,120,973
4
$332M 5%
5,368,451
5
$253M 3.81%
9,011,651
6
$223M 3.37%
4,636,146
-4,049,325
7
$184M 2.78%
5,605,129
8
$182M 2.75%
3,556,810
-1,219,738
9
$157M 2.37%
4,933,594
+558,377
10
$151M 2.28%
4,417,258
11
$149M 2.25%
18,417,458
12
$140M 2.11%
5,614,428
+1,056,561
13
$122M 1.84%
+243,540
14
$117M 1.76%
3,115,008
-710,000
15
$112M 1.69%
4,736,214
16
$112M 1.69%
3,593,052
17
$104M 1.56%
4,871,067
+692,000
18
$103M 1.56%
5,283,976
-61,655
19
$93.7M 1.41%
1,655,447
20
$93.5M 1.41%
2,107,149
-28,932
21
$92.3M 1.39%
936,583
-13,655
22
$84.9M 1.28%
+2,613,623
23
$80.8M 1.22%
357,005
-28,385
24
$78.3M 1.18%
+118,916
25
$76.3M 1.15%
3,865,808
+155,109
1
2 3 4